LABORATOIRE ORVIZ : revenue, balance sheet and financial ratios

LABORATOIRE ORVIZ is a French company founded 36 years ago, specialized in the sector Fabrication de matériel médico-chirurgical et dentaire. Based in ROMILLY-SUR-SEINE (10100), this company of category PME shows in 2020 a revenue of 1.5 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - LABORATOIRE ORVIZ (SIREN 950601575)
Indicator 2025 2024 2023 2022 2021 2020 2017 2016
Revenue N/C N/C N/C N/C N/C 1 496 735 € 1 017 747 € 892 893 €
Net income -410 606 € -78 376 € 40 274 € 15 250 € 61 190 € -68 048 € 106 781 € 67 880 €
EBITDA N/C N/C N/C N/C N/C -102 741 € 141 926 € 49 747 €
Net margin N/C N/C N/C N/C N/C -4.5% 10.5% 7.6%

Revenue and income statement

In 2025, LABORATOIRE ORVIZ records a net loss of 411 k€. This deficit will reduce equity on the balance sheet.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-410 606 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 1022%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 6%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

1022.454%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

5.95%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

61.1%

Solvency indicators evolution
LABORATOIRE ORVIZ

Sector positioning

Debt ratio
1022.45 2025
2023
2024
2025
Q1: 5.49
Med: 17.07
Q3: 41.92
Watch +7 pts over 3 years

In 2025, the debt ratio of LABORATOIRE ORVIZ (1022.45) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.

Financial autonomy
5.95% 2025
2023
2024
2025
Q1: 36.67%
Med: 56.53%
Q3: 69.09%
Watch

In 2025, the financial autonomy of LABORATOIRE ORVIZ (6.0%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 93.11. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

93.113

Liquidity indicators evolution
LABORATOIRE ORVIZ

Sector positioning

Liquidity ratio
93.11 2025
2023
2024
2025
Q1: 181.98
Med: 251.18
Q3: 365.98
Watch

In 2025, the liquidity ratio of LABORATOIRE ORVIZ (93.11) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
LABORATOIRE ORVIZ

Positioning of LABORATOIRE ORVIZ in its sector

Comparison with sector Fabrication de matériel médico-chirurgical et dentaire

Similar companies (Fabrication de matériel médico-chirurgical et dentaire)

Compare LABORATOIRE ORVIZ with other companies in the same sector:

Frequently asked questions about LABORATOIRE ORVIZ

What is the revenue of LABORATOIRE ORVIZ ?

The revenue of LABORATOIRE ORVIZ in 2020 is 1.5 M€.

Is LABORATOIRE ORVIZ profitable?

LABORATOIRE ORVIZ recorded a net loss in 2025.

Where is the headquarters of LABORATOIRE ORVIZ ?

The headquarters of LABORATOIRE ORVIZ is located in ROMILLY-SUR-SEINE (10100), in the department Aube.

Where to find the tax return of LABORATOIRE ORVIZ ?

The tax return of LABORATOIRE ORVIZ is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does LABORATOIRE ORVIZ operate?

LABORATOIRE ORVIZ operates in the sector Fabrication de matériel médico-chirurgical et dentaire (NAF code 32.50A). See the 'Sector positioning' section above to compare the company with its competitors.